{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:29:45Z","timestamp":1762100985605},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.eimc.2008.09.012","type":"journal-article","created":{"date-parts":[[2009,9,23]],"date-time":"2009-09-23T21:01:54Z","timestamp":1253739714000},"page":"13-16","source":"Crossref","is-referenced-by-count":9,"title":["Actividad comparativa de la daptomicina frente a Staphylococcus aureus resistente a meticilina y frente a estafilococos coagulasa negativa"],"prefix":"10.1016","volume":"28","author":[{"given":"Juan J.","family":"Picazo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Betriu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iciar","family":"Rodr\u00edguez-Avial","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"Culebras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F\u00e1tima","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eimc.2008.09.012_bib1","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1157\/13120413","article-title":"Staphylococcus spp. en Espa\u00f1a: situaci\u00f3n actual y evoluci\u00f3n de la resistencia a antimicrobianos (1986\u20132006)","volume":"26","author":"Cuevas","year":"2008","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.eimc.2008.09.012_bib2","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1157\/13095373","article-title":"Vigilancia de resistencias a los antimicrobianos: estudio VIRA 2006","volume":"24","author":"Picazo","year":"2006","journal-title":"Enferm Infecc Microbiol Clin"},{"issue":"Suppl 3","key":"10.1016\/j.eimc.2008.09.012_bib3","doi-asserted-by":"crossref","first-page":"S165","DOI":"10.1086\/519474","article-title":"Microbiology of antibiotic resistance in Staphylococcus aureus","volume":"45","author":"Appelbaum","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2008.09.012_bib4","doi-asserted-by":"crossref","first-page":"7S","DOI":"10.1016\/S0002-9343(98)00149-1","article-title":"T he emergence of Staphylococcus aureus with reduced susceptibility to vancomycin in Japan","volume":"104","author":"Hiramatsu","year":"1998","journal-title":"Am J Med"},{"key":"10.1016\/j.eimc.2008.09.012_bib5","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJM199902183400701","article-title":"Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group","volume":"340","author":"Smith","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eimc.2008.09.012_bib6","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1128\/CMR.15.3.430-438.2002","article-title":"Vancomycin resistance in staphylococci","volume":"15","author":"Srinivasan","year":"2002","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.eimc.2008.09.012_bib7","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.ijantimicag.2006.12.011","article-title":"Surveillance analysis of decreasing susceptibility of Staphylococcus aureus to vamcomycin using a mathematical model","volume":"29","author":"Rodr\u00edguez-Morales","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.eimc.2008.09.012_bib8","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1093\/jac\/dkm258","article-title":"Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05","volume":"60","author":"Steinkraus","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2008.09.012_bib9","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.1128\/JCM.01388-06","article-title":"Increased vancomycin MICs for Staphylococcus aureus clinical isolates from a university hospital during a 5-year period","volume":"44","author":"Wang","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.eimc.2008.09.012_bib10","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1128\/JCM.42.6.2398-2402.2004","article-title":"Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia","volume":"42","author":"Sakoulas","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.eimc.2008.09.012_bib11","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1086\/421946","article-title":"Nosocomial bloodstream infections in US hospitals: Analysis of 24,179 cases from a prospective nationwide surveillance study","volume":"39","author":"Wisplinghoff","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2008.09.012_bib12","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0213-005X(02)72853-X","article-title":"Vigilancia de resistencias a los antimicrobianos: estudio VIRA","volume":"20","author":"Picazo","year":"2002","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.eimc.2008.09.012_bib13","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1157\/13067619","article-title":"Vigilancia de resistencia a los antimicrobianos: estudio VIRA 2004","volume":"22","author":"Picazo","year":"2004","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.eimc.2008.09.012_bib14","unstructured":"Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard. M7-A7. 7th ed. Wayne: Clinical and Laboratory Standards Institute, 2006."},{"key":"10.1016\/j.eimc.2008.09.012_bib15","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Eighteenth informational supplement. M100-S18. Wayne: Clinical and Laboratory Standards Institute, 2008."},{"key":"10.1016\/j.eimc.2008.09.012_bib16","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1001\/archinte.166.19.2138","article-title":"High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: Efficacy and toxicity","volume":"166","author":"Hidayat","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.eimc.2008.09.012_bib17","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1128\/AAC.00422-06","article-title":"Isolates with low-level vancomycin resistance associated with persistent methicillin-resistant Staphylococcus aureus bacteremia","volume":"50","author":"Howden","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2008.09.012_bib18","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1128\/AAC.50.3.1079-1082.2006","article-title":"Correlation between reduced daptomycin susceptibility and vancomycin resistance in vancomycin-intermediate Staphylococcus aureus","volume":"50","author":"Cui","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2008.09.012_bib19","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1086\/504084","article-title":"An association between reduced susceptibility to daptomycin and reduced susceptibility to vancomycin in Staphylococcus aureus","volume":"42","author":"Patel","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2008.09.012_bib20","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1086\/507109","article-title":"The activity of daptomycin against wild-type Staphylococcus aureus and strains with reduced susceptibility to vancomycin","volume":"43","author":"Sader","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2008.09.012_bib21","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1086\/428616","article-title":"Daptomycin-resistant, methicillin-resistant Staphylococcus aureus bacteremia","volume":"40","author":"Mangili","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2008.09.012_bib22","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1128\/JCM.44.2.655-656.2006","article-title":"Treatment failure resulting from resistance of Staphylococcus aureus to daptomycin","volume":"44","author":"Skiest","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.eimc.2008.09.012_bib23","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1086\/520655","article-title":"Perspectives on daptomycin resistance, with emphasis on resistance in Staphylococcus aureus","volume":"45","author":"Boucher","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2008.09.012_bib24","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.diagmicrobio.2008.01.012","article-title":"In vitro activity of daptomycin against multidrug-resistant Staphylococcus aureus and S. aureus with known virulence factors, including community-acquired methicillin-resistant isolates","volume":"61","author":"Anastasiou","year":"2008","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.eimc.2008.09.012_bib25","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1128\/AAC.00526-06","article-title":"In vitro activity of daptomycin against methicillin-resistant Staphylococcus aureus, including heterogeneously glycopeptide-resistant strains","volume":"50","author":"Diederen","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2008.09.012_bib26","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1128\/AAC.00945-07","article-title":"Inhibitory activities of 11 antimicrobial agents and bactericidal activities of vancomycin and daptomycin against invasive methicillin-resistant Staphylococcus aureus isolates obtained from 1999 through 2006","volume":"52","author":"Holmes","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2008.09.012_bib27","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.diagmicrobio.2006.10.007","article-title":"Evaluation of the in vitro activity of daptomycin against 19615 clinical isolates of Gram-positive cocci collected in North American hospitals (2002\u20132005)","volume":"57","author":"Pfaller","year":"2007","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.eimc.2008.09.012_bib28","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/j.1469-0691.2006.01550.x","article-title":"Antimicrobial susceptibility of gram-positive bacteria isolated from European medical centres: Results of the Daptomycin Surveillance Programme (2002\u20132004)","volume":"12","author":"Sader","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.eimc.2008.09.012_bib29","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/jac\/dkh143","article-title":"Daptomycin activity and spectrum: A worldwide sample of 6737 clinical gram-positive organisms","volume":"53","author":"Streit","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2008.09.012_bib30","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJMoa053783","article-title":"Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus","volume":"355","author":"Fowler","year":"2006","journal-title":"N Engl J Med"}],"container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X09001517?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X09001517?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,16]],"date-time":"2018-12-16T12:29:12Z","timestamp":1544963352000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213005X09001517"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S0213005X09001517"],"URL":"https:\/\/doi.org\/10.1016\/j.eimc.2008.09.012","relation":{},"ISSN":["0213-005X"],"issn-type":[{"value":"0213-005X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}